AVXL vs. LTBR

Last updated Apr 2, 2026

Compare and contrast key facts about Anavex Life Sciences Corp. (AVXL) and Lightbridge Corporation (LTBR).

Performance

AVXL vs. LTBR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Anavex Life Sciences Corp. (AVXL) and Lightbridge Corporation (LTBR). The values are adjusted to include any dividend payments, if applicable.

AVXL vs. LTBR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AVXL Anavex Life Sciences Corp.	-12.92%	-66.85%	15.36%	0.54%	-46.60%	221.11%	108.49%	66.03%	-51.55%	-18.69%
LTBR Lightbridge Corporation	-15.98%	167.23%	47.35%	-17.48%	-41.28%	56.62%	-6.00%	-31.19%	-55.33%	7.02%

Fundamentals

EPS AVXL : -$0.46 LTBR : -$0.73
Total Revenue (TTM) AVXL : $0.00 LTBR : $0.00
Gross Profit (TTM) AVXL : $0.00 LTBR : $0.00
EBITDA (TTM) AVXL : -$28.87M LTBR : -$12.38M

Returns By Period

In the year-to-date period, AVXL achieves a -12.92% return, which is significantly higher than LTBR's -15.98% return. Over the past 10 years, AVXL has outperformed LTBR with an annualized return of -4.72%, while LTBR has yielded a comparatively lower -10.94% annualized return.

AVXL

• 1D: 0.98%
• 1M: -31.57%
• YTD: -12.92%
• 6M: -65.59%
• 1Y: -61.35%
• 3Y*: -28.75%
• 5Y*: -27.41%
• 10Y*: -4.72%

LTBR

• 1D: -0.38%
• 1M: -18.06%
• YTD: -15.98%
• 6M: -48.17%
• 1Y: 42.93%
• 3Y*: 37.33%
• 5Y*: 10.69%
• 10Y*: -10.94%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

AVXL vs. LTBR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVXL

AVXL Risk / Return Rank: 12
AVXL Sharpe Ratio Rank: 11
AVXL Sortino Ratio Rank: 14
AVXL Omega Ratio Rank: 13
AVXL Calmar Ratio Rank: 12
AVXL Martin Ratio Rank: 12

LTBR

LTBR Risk / Return Rank: 58
LTBR Sharpe Ratio Rank: 54
LTBR Sortino Ratio Rank: 65
LTBR Omega Ratio Rank: 61
LTBR Calmar Ratio Rank: 56
LTBR Martin Ratio Rank: 55

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVXL vs. LTBR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Anavex Life Sciences Corp. (AVXL) and Lightbridge Corporation (LTBR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AVXL	LTBR	Difference
Sharpe ratio Return per unit of total volatility	-0.69	0.40	-1.09
Sortino ratio Return per unit of downside risk	-0.76	1.42	-2.19
Omega ratio Gain probability vs. loss probability	0.89	1.16	-0.28
Calmar ratio Return relative to maximum drawdown	-0.80	0.66	-1.46
Martin ratio Return relative to average drawdown	-1.38	1.33	-2.70
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AVXL vs. LTBR - Sharpe Ratio Comparison

The current AVXL Sharpe Ratio is -0.69, which is lower than the LTBR Sharpe Ratio of 0.40. The chart below compares the historical Sharpe Ratios of AVXL and LTBR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	AVXL	LTBR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.69	0.40	-1.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.33	0.10	-0.43
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.06	-0.10	+0.05
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	-0.13	+0.08

Correlation

The correlation between AVXL and LTBR is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

AVXL vs. LTBR - Dividend Comparison

Neither AVXL nor LTBR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

AVXL vs. LTBR - Drawdown Comparison

The maximum AVXL drawdown since its inception was -97.06%, roughly equal to the maximum LTBR drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for AVXL and LTBR.

Drawdown Indicators

	AVXL	LTBR	Difference
Max Drawdown Largest peak-to-trough decline	-97.06%	-99.96%	+2.90%
Max Drawdown (1Y) Largest decline over 1 year	-79.57%	-64.47%	-15.10%
Max Drawdown (5Y) Largest decline over 5 years	-90.51%	-83.72%	-6.79%
Max Drawdown (10Y) Largest decline over 10 years	-90.51%	-95.69%	+5.18%
Current Drawdown Current decline from peak	-89.26%	-99.74%	+10.48%
Average Drawdown Average peak-to-trough decline	-64.89%	-94.99%	+30.10%
Ulcer Index Depth and duration of drawdowns from previous peaks	46.39%	31.96%	+14.43%

Volatility

AVXL vs. LTBR - Volatility Comparison

Anavex Life Sciences Corp. (AVXL) has a higher volatility of 46.94% compared to Lightbridge Corporation (LTBR) at 18.17%. This indicates that AVXL's price experiences larger fluctuations and is considered to be riskier than LTBR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AVXL	LTBR	Difference
Volatility (1M) Calculated over the trailing 1-month period	46.94%	18.17%	+28.77%
Volatility (6M) Calculated over the trailing 6-month period	82.21%	71.07%	+11.14%
Volatility (1Y) Calculated over the trailing 1-year period	88.81%	107.94%	-19.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	83.15%	109.09%	-25.94%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.59%	105.86%	-20.27%

Financials